Gene therapy is an advanced biomedical approach with immense medical potential. It involves intentionally modifying an individual's genes to treat or prevent diseases. This therapeutic strategy aims to address the fundamental causes of a patient's illness by correcting, replacing, or introducing specific genetic material. Gene therapy holds the promise of fundamentally changing the treatment of genetic disorders, certain cancers, and other chronic diseases, providing targeted and personalized solutions.
Gene therapy is a multi-step process. Generally, it includes several steps: disease diagnosis and gene selection, therapeutic gene design, precise sequence synthesis, vector construction (viral vectors such as adenoviruses, or non-viral vectors), transfection or delivery of therapeutic genes, and intracellular gene expression.
Tsingke provides comprehensive support for gene therapy researchers, offering a rich array of products and services. Our products include reagents, probes, and oligo suitable for studying disease mechanisms and validating target genes. Additionally, we provide services such as gene synthesis, plasmid preparation, viral vector packaging, and protein expression, contributing to the screening of potential drug carriers and optimizing them to enhance delivery efficiency, increase the expression of the gene of interest (GOI), reduce immune reactions, and minimize off-target effects, among other advantages.
